LEVEL BIOLEVEL BIOLEVEL BIO

LEVEL BIO

No trades
See on Supercharts
Market capitalization
‪20.29 M‬SEK
−0.169SEK
‪−9.48 M‬SEK
‪26.10 M‬SEK
‪46.82 M‬
Beta (1Y)
−4.61
Employees (FY)
13
Change (1Y)
+1 +8.33%
Revenue / Employee (1Y)
‪2.01 M‬SEK
Net income / Employee (1Y)
‪−728.92 K‬SEK

About LEVEL BIO


CEO
Joakim Grånemo
Headquarters
Nacka
Founded
1998
ISIN
SE0000885501
FIGI
BBG000PQNN44
Level Bio AB engages in the development, manufacturing, and marketing of instruments for deoxyribonucleic acid analysis. Its products include Clinical diagnostics, Extraction and purification, Biobank, General lab equipment, Next-generation sequencing, PCR, Cloning and Single-cell. The Company was founded in 1998 and is headquartered in Nacka, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LEVBIO is 0.200 SEK — it has decreased by −13.04% in the past 24 hours. Watch LEVEL BIO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange LEVEL BIO stocks are traded under the ticker LEVBIO.
LEVBIO stock has fallen by −15.61% compared to the previous week, the month change is a −31.27% fall, over the last year LEVEL BIO has showed a −37.50% decrease.
LEVBIO reached its all-time high on Jun 7, 2024 with the price of 0.500 SEK, and its all-time low was 0.232 SEK and was reached on Dec 12, 2024. View more price dynamics on LEVBIO chart.
See other stocks reaching their highest and lowest prices.
LEVBIO stock is 15.00% volatile and has beta coefficient of −4.61. Track LEVEL BIO stock price on the chart and check out the list of the most volatile stocks — is LEVEL BIO there?
Yes, you can track LEVEL BIO financials in yearly and quarterly reports right on TradingView.
LEVBIO net income for the last quarter is ‪−888.00 K‬ SEK, while the quarter before that showed ‪−3.16 M‬ SEK of net income which accounts for 71.93% change. Track more LEVEL BIO financial stats to get the full picture.
No, LEVBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 13.00 employees. See our rating of the largest employees — is LEVEL BIO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEVEL BIO EBITDA is ‪−8.90 M‬ SEK, and current EBITDA margin is −31.49%. See more stats in LEVEL BIO financial statements.
Like other stocks, LEVBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEVEL BIO stock right from TradingView charts — choose your broker and connect to your account.